Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD

30.11.2023 - VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) - Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage pharmaceutical development company, is pleased to ... Seite 1

Related Keywords

Japan , China , Chinese , Christopherj Moreau , , Chinese Patent Office , Algernon Pharmaceuticals , Algernon Pharmaceuticals Registereda Old Chart , Lgernon Pharmaceuticals Registereda Old Kurs , Lgernon Pharmaceuticals Registereda Old Aktie ,